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Abstract
C–H bonds are ubiquitous structural units of organic molecules; while these bonds are generally 
considered to be chemically inert, the recent emergence of methods for C–H functionalization 
promises to transform the way synthetic chemistry is performed. The intermolecular amination of 
C–H bonds represents a particularly desirable and challenging transformation for which no 
efficient, highly selective, and renewable catalysts exist. Here we report the directed evolution of 
an iron-containing enzymatic catalyst, based on a cytochrome P450 monooxygenase, for the 
highly enantioselective, intermolecular amination of benzylic C–H bonds. The biocatalyst is 
capable of up to 1,300 turnovers, exhibits excellent enantioselectivities, and provides access to 
valuable benzylic amines. Iron complexes are generally poor catalysts for C–H amination: in this 
catalyst, the enzyme’s protein framework confers activity on an otherwise unreactive iron-heme 
cofactor.
Table of contents summary
The intermolecular amination of C–H bonds is an enabling transformation for the synthesis of 
nitrogen-containing molecules, yet a challenging activity for chemical catalysts. Here we engineer 
an iron-based enzyme for this reaction, demonstrating that a protein can confer a difficult new 
function upon an otherwise unreactive base metal.
C–H bonds may be the most common functional groups in organic molecules but are 
typically considered inert toward chemical transformation. By selectively acting on these 
bonds and installing new functional groups directly into the hydrocarbon framework of 
organic compounds, C–H functionalization technology has the potential to streamline 
synthetic routes, leading to less wasteful and more sustainable chemical production.1–3 
Modern C–H functionalization methods, however, rely heavily on catalytic complexes of 
precious transition metals (such as rhodium, ruthenium, and iridium), which are neither 
cheap nor green.1 Many enzymes, by contrast, catalyze very challenging reactions using 
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base metals; their activities are often only possible because the protein plays a key role, 
modifying or enhancing the inherent reactivity of the metal cofactor.4 We envisioned that 
enzymes dependent only on base metals could be exploited through reaction design and 
evolution to perform non-biological C–H functionalization reactions, potentially with 
efficiencies and selectivities exceeding those of known chemical catalysts.
Due to the presence of nitrogen in many bioactive synthetic and natural compounds, 
methods for directly transforming sp3-hybridized C–H bonds into C–N bonds have been 
pursued intensively.5–9 Many of the methods that have been developed are either 
intramolecular (requiring that a nitrogen source already be present in the same molecule as 
the targeted C–H bond) or utilize directing groups (also requiring the presence of specific 
functionality in the starting material). An elegant yet more elusive transformation is the 
intermolecular C–H amination of unfunctionalized hydrocarbons; such a reaction provides a 
dramatically simplifying and convergent disconnection for the synthesis of amines from 
alkanes (Fig. 1). Recognizing the potential of this transformation, several groups have 
pursued innovative strategies for intermolecular C–H amination. While many of these 
methods are racemic,10–14 enantioselective intermolecular C–H amination via the generation 
and transfer of metal nitrenoids has been developed using rhodium,15–17 ruthenium,18,19 and 
manganese19,20 catalysts. Highly diastereoselective C–H amination using a chiral nitrogen 
source has also been achieved using a rhodium catalyst.21 These systems represent major 
advances in C–H functionalization; none, however, offers the combination of high catalytic 
efficiency (turnover), high enantioselectivity across diverse substrates, and ready access to 
the chiral catalyst.
Cytochrome P450 monooxygenases are nature’s catalysts for the direct insertion of oxygen 
into C–H bonds. These iron-dependent enzymes perform hydroxylation with high reaction 
rates and turnovers, and do so under mild physiological conditions.22 They also act with 
excellent selectivity in complex settings, often hydroxylating only one C–H bond out of 
many in diverse secondary metabolites.23 In contrast to this strategy for oxygenation, nature 
does not introduce nitrogen into organic molecules via C–H functionalization. Biosynthetic 
routes to amines instead rely exclusively on functional group manipulation of pre-oxidized 
substrates, and biocatalytic multi-enzyme cascades have been engineered for formal C–H 
amination using this general approach.24,25
In striking contrast to both natural and synthetic amination strategies, it has been shown that 
heme proteins can catalyze nitrene transfer under appropriate reaction conditions.26–32 In 
particular, variants of cytochrome P450BM3 from Bacillus megaterium that feature a serine 
axial ligand to the heme iron in place of the wild-type cysteine ligand, which we term 
cytochrome P411s,33 are proficient catalysts for nitrene transfer. Based on this manifold, we 
envisioned the catalytic cycle for intermolecular amination shown in Figure 2. First, 
reduction of the ferric state of the heme cofactor, with electrons derived from NADPH, gives 
the ferrous state 1. Reaction with a nitrene source, here tosyl azide (TsN3), then provides the 
putative iron nitrenoid 2. Subsequent reaction of this intermediate with an alkane such as 4-
ethylanisole (3) would deliver the C–H amination product 4 and regenerate the ferrous state 
of the catalyst (1). A competing process observed in P411-catalyzed nitrene transfer is the 
reduction of the nitrenoid, generating the undesired by-product p-toluenesulfonamide 
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(TsNH2, 5). Cytochrome P411 catalysts have been identified for intramolecular C–H 
amination reactions;26,27 in these cases, the targeted C–H bond is necessarily present in the 
enzyme active site when the reactive nitrenoid 2 is formed, biasing productive C–H 
amination over the deleterious nitrenoid reduction pathway. In contrast, a catalyst for the 
desired intermolecular amination must bind a separate alkane substrate and promote its 
amination faster than the transient nitrenoid species is consumed in the reductive side 
reaction.
Results and discussion
Reaction discovery and directed evolution
In initial studies, we found that almost all cytochrome P411s reported to date display no 
activity toward intermolecular C–H amination of alkane 3 – including catalysts that were 
developed for ostensibly similar reactions such as intramolecular C–H amination26,27 and 
intermolecular aziridination28 – instead they exclusively reduce the azide to the sulfonamide 
5 (Supplementary Table 1). Other heme-containing proteins, as well as the heme cofactor 
alone (iron protoporphyrin IX), are similarly inactive (Supplementary Table 2). Remarkably, 
however, we found that P411BM3 variant P-4, engineered for the imidation of allylic 
sulfides,29 shows promiscuous activity toward intermolecular C–H amination. Under 
anaerobic conditions, 4-ethylanisole (3) undergoes amination at the benzylic carbon in 11% 
yield and 14% ee by variant P-4, which differs from wild-type P450BM3 by 17 mutations 
(Fig. 3). Even more encouragingly, a single mutation to P-4, A82L (also identified in the 
context of the sulfimidation reaction), provides a greater than 4-fold improvement in yield 
(to 51%) and delivers the product 4 in 77% ee. Similarities between the nitrene transfer 
transition states of the sulfimidation and C–H insertion reactions may account for why 
evolution for one reaction engendered activity toward the other, leading to variants with 
expanded promiscuous capabilities toward nitrene transfer.
We next performed sequential rounds of site-saturation mutagenesis of selected residues in 
P-4 A82L and screening to improve C–H amination activity and enantioselectivity. We 
targeted sites in the heme domain that were either previously shown to impact the activity 
and/or selectivity of P450s, residues that are highly conserved in P450s, or residues that 
were already mutated in P-4 relative to wild-type P450BM3 (see Supplementary Information 
for details).34 The libraries were screened for enhanced C–H amination activity, and 
potential hits were subsequently evaluated for activity across a set of three substrates with 
different electronic demands for C–H amination: 4-ethylanisole (3), 4-ethyltoluene (6), and 
ethylbenzene (7, Fig. 3). Two mutations, A78V and F263L, improve activity and selectivity 
on all three substrates, yielding a catalyst that delivers the benzylic amine products as single 
enantiomers (>99% ee). A final mutation, E267D, is neutral with respect to the amination of 
4-ethylanisole but provides a two-fold improvement in the amination of ethylbenzene (7, to 
15% yield), as well as improving the reaction yield and/or selectivity in the C–H amination 
of other substrates (Supplementary Table 6). We call this final variant P411CHA, for 
“cytochrome P411 C–H aminase.” Under the conditions employed for evolution, this 
catalyst generates the benzylic amine 4 in 66% yield, with >99% ee and 1,000 turnovers in 
whole Escherichia coli cells. While 4-ethylanisole is electronically activated toward C–H 
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insertion,15 alkanes 6 and 7 are less activated and display much lower reactivity with the 
initial P411 variants. Over the course of evolution from variant P-4 to P411CHA, the 
amination of 4-ethylanisole was improved by 6-fold, while the effect on the amination of 
ethylbenzene was significantly greater (30-fold improvement). Thus, using an electronically 
activated substrate (4-ethylanisole) allowed the initial discovery of P411 C–H amination 
activity, from which variants that aminate inherently less reactive alkanes were derived.
Subsequent studies revealed that P411CHA can support up to 1,300 turnovers (Table 1, entry 
3), far exceeding the highest turnover number (TON) reported with any chiral transition 
metal complex for intermolecular, enantioselective C–H amination (the best reported is 85 
TON using a chiral manganese porphyrin).19 The reaction was optimized for yield by 
employing two equivalents of tosyl azide; under these conditions, the product 4 is obtained 
in 86% yield, with >99% ee and 670 turnovers (Table 1, entry 8). In contrast to the reported 
chemical protocols, the reaction with P411CHA takes place in water at room temperature; the 
reaction can also proceed under aerobic conditions, but the yield is 7-fold higher using the 
optimal anaerobic conditions (Supplementary Table 7).
Substrate scope studies
Scope studies, carried out using the yield-optimized conditions, revealed that cytochrome 
P411CHA aminates a diverse set of arene-containing hydrocarbons. Substitution of the 
aromatic ring is tolerated at para, meta, and ortho positions (Table 2, entries 2–4). While 
electron-withdrawing functionality reduces the reactivity of the alkane toward the metal 
nitrenoid, several halogenated ethylbenzenes are nevertheless functionalized with >100 
turnovers (entries 6–8). The cyclic alkanes indan and tetralin are excellent substrates (entries 
9 and 10), while the related 2,3-dihydrobenzofuran displays reduced reactivity (entry 11). 
Larger alkylarenes such as ethylnaphthalenes and 4-propylanisole are still accommodated in 
the enzyme active site, undergoing amination with varying levels of efficiency (entries 12–
14). Notably, the amination of 1-ethylnaphthalene delivers the nitrogen-containing fragment 
of the calcimimetic drug cinacalcet (Sensipar) with the correct absolute configuration (entry 
13).35 Furthermore, although the activity is low, the amination of the methyl group of 4-
methylanisole demonstrates that these catalysts are capable of functionalizing C–H bonds 
with bond dissociation energies as high as 90 kcal/mol (entry 15). Benzylic ethers are 
suitable substrates for amination, but the products are isolated in racemic form (entries 16–
17). For the amination of isochroman (entry 17), analysis of crude reaction mixtures 
demonstrated that the C–H insertion event is moderately enantioselective (65% ee), but the 
product undergoes racemization during purification on silica gel (Supplementary Table 10).
Notably, most of the alkanes evaluated undergo functionalization with excellent levels of 
enantioselectivity (>90% ee), a key advantage of this enzymatic approach over most reported 
metal catalysts. However, P411CHA displays several limitations with regard to substrate 
scope: it does not aminate substrates much larger than those shown here, nor does it 
functionalize benzylic positions adjacent to especially electron-deficient arenes 
(Supplementary Fig. 1). Interestingly, cumene and 4-methoxycumene are not aminated by 
P411CHA despite the presence of weak benzylic C–H bonds. We have also not found 
P411CHA to be active toward the amination of allylic or aliphatic C–H bonds, nor is it 
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capable of aminating non-benzylic ethers. The aromatic motif may be required for 
productive substrate binding or to sufficiently lower the activation barrier of C–H insertion. 
Directed evolution, however, may improve the activities described here and alter the 
substrate scope of these enzymes, potentially by modifying the binding site of the alkane. 
Just as evolution within the functional space of nitrene transfer engendered expanded 
amination activities, it is possible that non-benzylic amination will be accessible to future 
generations of P411 enzymes. Cytochrome P411CHA also has improved thermostability 
relative to P–4 (T50 is increased by ~3 °C, to 61 °C, Supplementary Table 11), suggesting it 
may serve as a robust starting point for the evolution of specialized enantioselective C–H 
amination catalysts.36
The enzymatic amination reaction can be performed on preparative scale: from a 0.25 mmol-
scale biotransformation, the benzylic amine 4 was isolated in 78% yield (59.5 mg, 610 TON, 
>99% ee). The reaction also proceeds with purified protein, albeit less efficiently than in 
whole cells: the P411 catalysts are capable of up to 190 TON in vitro vs. 1,300 TON in vivo 
(Supplementary Table 8). Furthermore, the tosyl group present in the C–H amination 
products may be removed via treatment with samarium diiodide,37 providing the 
corresponding primary amine with no erosion of enantiomeric excess (see Supplementary 
Information for details).
Rate experiments
The fact that amination activity throughout evolution is highly dependent on the electronic 
nature of the substrate (electron-rich substrates giving higher yields) suggests that C–H 
insertion is rate-determining. We questioned, however, whether improvements in yield arose 
from improved catalytic efficiency toward C–H amination or suppression of the competing 
azide reduction pathway (Fig. 2). Under in vitro conditions, initial rates are enhanced by 
greater than 8-fold for the amination of 4-ethylanisole by P411CHA compared to P-4, 
showing that the mutations indeed increase the rate of the productive reaction 
(Supplementary Fig. 2). Independent rate measurements conducted with deuterated alkane 8 
show a kinetic isotope effect (kH/kD) of 1.6 in the reaction catalyzed by P411CHA, 
suggesting only partial C–H bond cleavage in the amination transition state (Fig. 4a),5 while 
also providing further evidence for a rate-determining C–H insertion event.
Crystallography
We obtained an X-ray crystal structure of the penultimate variant in our lineage (P-4 A82L 
A78V F263L) at 1.70-Å resolution (Fig. 4b). The beneficial mutations identified in this 
study are all located in helices that line the active site; two mutations are located in the 
enzyme’s B′ helix (A82L, A78V) and two are located in the I helix (F263L, E267D). 
Residues in both of these helices are known to mediate substrate binding and/or impact 
selectivity in P450-catalyzed oxygenation reactions.38–40 Like two earlier reported P411 
structures,27,33 the structure of the evolved aminase adopts the P450 closed state typically 
induced by substrate binding. Compared to the structure of P411 variant P-I263F,27 which 
differs by only six mutations yet performs intermolecular C–H amination with trace activity 
(<1% yield), there are only minor movements of the protein scaffold, although the active-site 
residue L437 surprisingly adopts an unfavored backbone conformation. On average, the 
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volume of the heme distal pocket is reduced by approximately 10% in the evolved variant 
compared to P-I263F; the smaller active site potentially enforces productive substrate 
binding modes. These observations suggest that the mutations introduced on the path to 
P411CHA exert local effects that modulate interactions with the azide and alkane substrates 
in the active site. Docking simulations revealed plausible substrate conformations for nitrene 
transfer, in which the substrates are organized via van der Waals interactions with residues 
A87, L263, E267, and V328, among others (see Supplementary Information).
Conclusion
Cytochrome P411CHA displays the ability to aminate benzylic C–H bonds intermolecularly 
in diverse structures with high selectivity, demonstrating that a renewable protein catalyst 
based on iron (the most abundant transition metal in the earth’s crust) can solve a long-
standing challenge in synthetic chemistry. The protein does more than simply control the 
reactivity of a reactive metal complex – as in the native P450 monooxygenation reaction, the 
protein enables a function that the iron cofactor cannot perform on its own. Biocatalysts for 
non-natural reactions have alternatively been created by introducing precious metals (such as 
iridium and rhodium) into proteins.41–43 An artificial iridium metalloenzyme has been 
shown to perform nitrene transfer; this system is capable of up to ~300 turnovers in 
intramolecular C–H amination reactions.44 That P411CHA achieves intermolecular C–H 
amination with the native iron cofactor suggests that costly precious metals – and strategies 
for introduction of the non-native metal – are not necessary to achieve highly active 
biocatalysts for challenging non-natural reactions. The current work also describes an 
evolutionary pathway in which P411s evolved for a more readily accessible nitrene transfer 
reaction (sulfimidation) picked up promiscuous activity toward a more challenging reaction 
(intermolecular C–H amination). This strategy of stepwise evolution through increasingly 
challenging reactivities may be generally useful for engineering enzymes for new activities 
not readily found by testing wild-type proteins. Finally, the ability to accelerate C–H 
insertion via mutation suggests that cytochrome P411CHA may be a platform for evolving 
catalysts for diverse C–H functionalization reactions currently inaccessible to chemical 
catalysis.
Methods
Expression of P411BM3 variants
E. coli BL21 E. cloni cells carrying a plasmid encoding a P411 variant were grown 
overnight in 5 mL Luria-Bertani medium with 0.1 mg/mL ampicillin (LBamp, 37 °C, 250 
rpm). The preculture was used to inoculate 45 mL of Hyperbroth (HB) medium (prepared 
from AthenaES© powder, 0.1 mg/mL ampicillin) in a 125-mL Erlenmeyer flask; this culture 
was incubated at 37 °C, 230 rpm for 2 h. Cultures were then cooled on ice (20 min), and 
expression was induced with 0.5 mM IPTG and 1.0 mM 5-aminolevulinic acid (final 
concentrations). Expression was conducted at room temperature (23 °C), at 130 rpm, for 16–
18 h. Cultures were then centrifuged (2,600 x g, 10 min, 4 °C), and the pellets were 
resuspended to an OD600 of 30 in M9-N minimal media (no nitrogen). Aliquots of the cell 
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suspension (4 mL) were used to determine the P411 expression level by CO-binding assay 
after lysis by sonication.
Intermolecular C–H amination in whole E. coli cells
For amination bioconversions, the cells containing the P411 variant, at OD600 of 30 in M9-N 
media (grown as described above), were degassed by sparging with argon in sealed 6-mL 
crimp vials for at least 40 minutes. Separately, a glucose solution (250 mM in M9-N) was 
degassed by sparging with argon for at least 10 minutes. An oxygen depletion system (20 μL 
of a stock solution containing 14,000 U/mL catalase and 1,000 U/mL glucose oxidase in 0.1 
M KPi, pH 8.0) was added to 2-mL crimp vials. All solutions were uncapped and transferred 
into an anaerobic chamber. Resuspended cells (320 μL) were added to the vials, followed by 
glucose (40 μL, 250 mM in M9-N), alkane (10 μL of a DMSO stock), and tosyl azide (10 μL 
of a DMSO stock). Final concentrations were typically 2.5–5.0 mM alkane, 5.0 mM tosyl 
azide, and 25 mM glucose; final reaction volume was 400 μL. The vials were sealed, 
removed from the anaerobic chamber, and shaken at room temperature and 40 rpm for 16–
20 h. The reactions were quenched by addition of acetonitrile (400 μL) and internal standard 
(10 μL of a DMSO stock). This mixture was then transferred to a microcentrifuge tube and 
centrifuged at 20,000 x g for 10 minutes. The supernatant was transferred to a vial and 
analyzed by HPLC for yield. Reaction samples were extracted with cyclohexane and 
analyzed by chiral SFC (supercritical fluid chromatography) for enantiomeric excess (ee). 
Yield is calculated as mM reaction product divided by mM alkane starting material; TON is 
calculated as mM reaction product divided by mM P411, as determined by the CO-binding 
assay following cell lysis. Enantiomeric excess (ee) is calculated as (major enantiomer – 
minor enantiomer)/(major enantiomer + minor enantiomer).
Data availability
Complete experimental procedures, including synthesis methods for all compounds, 
characterization data, and details of bioconversion experiments are described in the 
Supplementary Information. The crystal structure of P411BM3 P-4 A82L A78V F263L has 
been deposited in the Research Collaboratory for Structural Bioinformatics Protein Data 
Bank (PDB) under accession code 5UCW.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Intermolecular C–H amination, a simplifying transformation for chiral amine synthesis
Intermolecular C–H amination enables direct and convergent functionalization in which a 
simple alkane and a nitrogen atom source are brought together in a single step. In principle, 
any C–H bond in the substrate is a potential site of functionalization.
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Figure 2. Proposed mechanism of cytochrome P411-catalyzed intermolecular C–H amination
Reaction of the aminating reagent, tosyl azide, with the ferrous porphyrin (1) generates an 
enzyme-bound iron nitrenoid intermediate (2). This nitrenoid then inserts into a C–H bond 
in the alkane, delivering a benzylic amine product. The nitrogen atoms in a plane represent 
the enzyme’s heme cofactor. Ts = 4-toluenesulfonyl; Ser = serine.
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Figure 3. Evolution of a cytochrome P411 catalyst for enantioselective C–H amination on 
increasingly challenging substrates
Directed evolution, via sequential rounds of site-saturation mutagenesis and screening, 
improved both the conversion and enantioselectivity of P411-catalyzed C–H amination. The 
initial variant P-4 shows significant activity only on the electronically-activated 4-
ethylanisole (3); evolved variants display activity on inherently less activated substrates. 
Reactions were performed using whole E. coli cells overexpressing the P411 variant, 
resuspended to OD600 = 30, with 5 mM alkane and 5 mM tosyl azide, under anaerobic 
conditions. Results are the average of experiments performed with duplicate cell cultures, 
each used to perform duplicate chemical reactions (four reactions total). Bars represent 
yield; numbers above bars represent enantiomeric excess (ee); both are color-coded to match 
the substrate (blue = 4-ethylanisole; red = 4-ethyltoluene; purple = ethylbenzene). Error bars 
correspond to one standard deviation. P-4 gives predominantly the S enantiomer in the 
amination of 4-ethylanisole (3); all other variant/substrate combinations give predominantly 
the R enantiomer.
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Figure 4. Kinetic isotope effect and enzyme structural studies
a, The kinetic isotope effect in enzymatic C–H amination was determined from independent 
in vitro rate experiments. b, Active site view of the P-4 A82L A78V F263L crystal structure, 
showing the heme in white and the iron atom in orange. Key active site residues are labeled 
and shown as sticks in blue. Residue S400 ligates the iron center; mutations at positions 78, 
82, 263, and 267 enhance C–H amination activity and/or selectivity. All beneficial mutations 
identified in this study lie in the P411 active site on the distal face of the heme.
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Table 1
Optimization of the P11CHA-catalyzed amination of 4-ethylanisole
Reactions were performed with whole E. coli cells overexpressing P411CHA, as in Figure 3. All reactions 
generate benzylic amine 4 in >99% ee.
entry mM 4-ethylanisole (3) mM tosyl azide yield (4) TON
1a 5 5 66% 1,000
2 7.5 7.5 51% 1,200
3b 10 10 41% 1,300
4 15 15 26% 1,200
5 20 20 20% 1,200
6 2.5 2.5 56% 430
7 2.5 3.75 80% 630
8c 2.5 5 86% 670
9 2.5 7.5 83% 640
10 2.5 10 78% 610
aConditions employed during evolution.
b
Turnover-optimized conditions.
c
Yield-optimized conditions, employed for evaluating the substrate scope.
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Table 2
Substrate scope of enzymatic intermolecular C–H amination
Reactions were performed in duplicate with whole E. coli cells overexpressing P411CHA at OD600 = 30 (~3 
μM enzyme), with 2.5 mM alkane and 5 mM tosyl azide.
†
Isolated yield from a reaction performed on 0.25-mmol scale (see Supplementary Information for details).
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